ALCOX:EPA
NicOx SA
0,30 €
0,00%
(0,00) 1D
12-окт., 17:35:10 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Mkt. cap
31,17 млн
Avg. vol.
159,77 миң
Volume
0,00
52-wk high
0,57 €
52-wk low
0,28 €
EPS
-0,03 €
Shares outstanding
97,55 млн
No. of employees
10
Mkt. cap
31,17 млн
Avg. vol.
159,77 миң
Volume
0,00
52-wk high
0,57 €
52-wk low
0,28 €
EPS
-0,03 €
Shares outstanding
97,55 млн
No. of employees
10
News stories
From web sources and news partners
Simply Wall Street
·
4 мүнөт мурун
After AbCellera Biologics' 125% Climb, The Story Has Changed
CoinDesk
·
2 саат мурун
Bitcoin rebounds above $83,000 as it decouples from tumbling Korean stocks and Nasdaq futures
Carroll County Mirror-Democrat
·
47 мүнөт мурун
Abishai Financial Asia Reports S&P 500 Tech-Led Advance
Yahoo Finance
·
49 мүнөт мурун
Stock Market: Will S&P 500 Open Up or Down Today?
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersВальбон, Прованс-Альп-Кот д'Азур, Франция
Sector-
Websitenicox.com